ASGR2
Basic information
Region (hg38): 17:7101322-7115700
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASGR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 18 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 2 | 2 |
Variants in ASGR2
This is a list of pathogenic ClinVar variants found in the ASGR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-7101587-G-A | Benign (Apr 24, 2018) | |||
17-7101590-G-A | Benign (Dec 31, 2019) | |||
17-7101663-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
17-7101685-C-G | not specified | Uncertain significance (Mar 28, 2024) | ||
17-7101700-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
17-7101706-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
17-7101729-A-C | not specified | Uncertain significance (Feb 27, 2023) | ||
17-7102136-C-G | not specified | Uncertain significance (Jul 26, 2022) | ||
17-7102145-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
17-7102165-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
17-7102177-G-A | not specified | Uncertain significance (May 11, 2022) | ||
17-7107119-C-T | not specified | Uncertain significance (Apr 04, 2023) | ||
17-7107142-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
17-7107264-C-G | not specified | Likely benign (Apr 09, 2024) | ||
17-7107270-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
17-7107279-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
17-7107899-C-T | not specified | Uncertain significance (May 23, 2023) | ||
17-7108477-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
17-7108488-G-A | not specified | Likely benign (Jan 31, 2024) | ||
17-7108500-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
17-7108534-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
17-7108761-G-T | not specified | Uncertain significance (Sep 14, 2023) | ||
17-7108822-A-G | not specified | Uncertain significance (Aug 04, 2023) | ||
17-7114132-T-C | not specified | Likely benign (Jun 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASGR2 | protein_coding | protein_coding | ENST00000380952 | 8 | 14379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.81e-10 | 0.0905 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.285 | 176 | 187 | 0.941 | 0.0000109 | 2065 |
Missense in Polyphen | 59 | 65.192 | 0.90502 | 810 | ||
Synonymous | 0.228 | 75 | 77.5 | 0.967 | 0.00000500 | 571 |
Loss of Function | 0.0601 | 14 | 14.2 | 0.983 | 6.09e-7 | 152 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000323 | 0.000309 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000171 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface.;
- Pathway
- Thyroid hormone synthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Asparagine N-linked glycosylation
(Consensus)
Intolerance Scores
- loftool
- 0.835
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.185
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.572
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asgr2
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- receptor-mediated endocytosis;cell surface receptor signaling pathway;viral process;protein N-linked glycosylation via asparagine;bone mineralization;regulation of protein stability;lipid homeostasis
- Cellular component
- plasma membrane;integral component of membrane;endoplasmic reticulum quality control compartment;perinuclear region of cytoplasm
- Molecular function
- asialoglycoprotein receptor activity;protein binding;carbohydrate binding